LarmorBio Presents New Research at ENDO on the Ability of MMR Technology to Assess Cardiometabolic Disease Risk BOSTON, MA, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- LarmorBio today announced the presentation of three groundbreaking studies at the U.S. Endocrine Society (ENDO) 2025 conference, showcasing the power of its proprietary microscale magnetic resonance (MMR) technology in profiling oxidative stress (OS) as a sensitive, non-invasive biomarker for early detection, monitoring,...